| abstract |
Novel compounds are described. These compounds have groups which have acidic groups, basic groups, substituted amino or N-acyl groups and optionally hydroxylated alkane moieties. Also described are pharmaceutical compositions containing the inhibitors of the present invention. Also described is a method of inhibiting neuraminidase in a sample that is believed to contain neuraminidase. Assays for screening conjugates, antibodies, polymers, antigenic substances and neuraminidase activity of labeled compounds of the invention are also described. |